These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3251366)

  • 21. [Clinical evaluation of aztreonam (AZT) in the treatment of complicated urinary tract infections].
    Mizutani S; Iwao N; Miyoshi S; Kameoka H; Yano H; Kishimoto T; Sakurai T; Wakatsuki A; Nakamura T; Honda M
    Hinyokika Kiyo; 1989 Dec; 35(12):2155-61. PubMed ID: 2694836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study of the effectiveness and renal tolerance of aztreonam (1 daily dosage) and gentamycin (2 daily doses) in the therapy of renal and urinary infections].
    Bonadio M; Maccanti O; Pulitanò L; Galigani P; Palla R
    G Ital Chemioter; 1985; 32(2):459-63. PubMed ID: 3914435
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical experience with aztreonam in urinary and respiratory tract infections.
    Hollingsworth JA; Donohoe JF; Hone R; Keelan PJ
    Curr Med Res Opin; 1984; 9(5):316-22. PubMed ID: 6397335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aztreonam.
    Clark P
    Obstet Gynecol Clin North Am; 1992 Sep; 19(3):519-28. PubMed ID: 1436929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of aztreonam in pediatric patients: a review.
    Bosso JA; Black PG
    Pharmacotherapy; 1991; 11(1):20-5. PubMed ID: 1902290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of aztreonam in patients suffering from urinary tract infections with contraindications for the use of aminoglycosides.
    Fraschini F; Scaglione F; Alessandria M; Gattei G
    Chemioterapia; 1986 Oct; 5(5):319-21. PubMed ID: 3791478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prophylaxis in prostatic surgery with aztreonam. Our experience].
    Moyano Calvo JL; Arellano Gañán R; Sempere Gutiérrez A; Sanz Sacristán J; Teba del Pino F; Melón Rey FJ; Herrero Torres L; Pereira Sanz I
    Arch Esp Urol; 1992; 45(6):519-21. PubMed ID: 1510489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical efficacy of aztreonam in patients with complicated urinary tract infections].
    Yoshida K; Uchijima Y; Kobayashi N; Suwata J; Nakame Y; Saitoh H; Negishi T; Yamada T; Kageyama Y; Kura N
    Hinyokika Kiyo; 1988 Dec; 34(12):2225-32. PubMed ID: 3071130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Well-controlled comparative study on aztreonam and cefoperazone in the treatment of complicated urinary tract infections].
    Ohmori H; Kumon H; Kumamoto Y; Sakai S; Niijima T; Kishi H; Ohkoshi M; Kawamura N; Naide Y; Nishiura T
    Jpn J Antibiot; 1986 Jan; 39(1):24-56. PubMed ID: 3517407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Aztreonam vs norfloxacin: a comparative study of the treatment of urinary tract infections in ambulatory and hospitalized patients].
    Puppo P; Germinale F; De Rose AF
    Clin Ter; 1989 Apr; 129(2):113-21. PubMed ID: 2525996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical study on aztreonam in pediatrics].
    Niino M; Kida K; Matsuda H; Murase M
    Jpn J Antibiot; 1985 Nov; 38(11):3334-42. PubMed ID: 4094066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical experience with aztreonam in the pediatric field].
    Kobashi H; Aihara R; Nishioka A; Oohara K; Okamoto T
    Jpn J Antibiot; 1985 Nov; 38(11):3316-22. PubMed ID: 4094064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Aztreonam: prevention of bacteremia in urologic surgery in patients with urinary infection].
    Dalet F; del Río G; Rabinad E
    Med Clin (Barc); 1988 Jan; 90(3):101-5. PubMed ID: 3352336
    [No Abstract]   [Full Text] [Related]  

  • 34. Employment of azthreonam in generalized and localized infections determined by gram negative bacteria.
    Terragna A; Giacchino R; Viscoli C; Consani G
    G Ital Chemioter; 1985; 32(2):423-5. PubMed ID: 3833582
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapeutic evaluation of aztreonam in the treatment of infections of the urinary tract in another 800 patients].
    Cortecchia V; Buli P; Brunocilla E; Concetti S; Martelli A
    G Ital Chemioter; 1985; 32(2):449-51. PubMed ID: 3914434
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical evaluation of the combination of carumonam and fosfomycin in the treatment of complicated urinary tract infection].
    Kakizaki H; Ishii N; Murakami S; Suzuki K; Takamizawa A; Hirano J; Mitobe K; Saito M; Hirano K; Imamura A
    Hinyokika Kiyo; 1990 Jun; 36(6):731-5. PubMed ID: 2239570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
    LeFrock JL; Smith BR; Chandrasekar P; Rolston KV; Molavi A; Kannangara W
    Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of Ro 17-2301 (AMA-1080) and amikacin in complicated urinary tract infections.
    Hahn LB; Iribarren M; Barclay C; Casellas J; Traballi C; Farinati A
    Chemioterapia; 1987 Jun; 6(2 Suppl):519-21. PubMed ID: 3334614
    [No Abstract]   [Full Text] [Related]  

  • 39. Aztreonam for severe infections.
    Wood MJ; Smith G; Farrell ID
    Chemioterapia; 1987 Jun; 6(2 Suppl):384-5. PubMed ID: 3509453
    [No Abstract]   [Full Text] [Related]  

  • 40. Aztreonam versus cefamandole in the treatment of urinary tract infections.
    Giamarellou H; Koratzanis G; Kanellakopoulou K; Galanakis N; Papoulias G; el Messidi M; Daikos G
    Chemioterapia; 1984 Apr; 3(2):127-31. PubMed ID: 6543431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.